ERCC1 expression as a prognostic and predictive factor in patients with non-small cell lung cancer: a meta-analysis

@article{Jiang2012ERCC1EA,
  title={ERCC1 expression as a prognostic and predictive factor in patients with non-small cell lung cancer: a meta-analysis},
  author={Jingwei Jiang and Xiaohua Liang and X Li-Jun Zhou and Ruofan Huang and Zhaohui Chu and Qiong Zhan},
  journal={Molecular Biology Reports},
  year={2012},
  volume={39},
  pages={6933-6942}
}
It is hypothesized that high expression of the excision repair cross-complementation group 1 (ERCC1) gene might be a positive prognostic factor, but predict decreased sensitivity to platinum-based chemotherapy. Results from the published data are inconsistent. To derive a more precise estimation of the relationship between ERCC1 and the prognosis and predictive response to chemotherapy of non-small cell lung cancer (NSCLC), a meta-analysis was performed. An electronic search of the PubMed and… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 28 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 44 references

a randomized phase II trial in Japanese patients with completely resected non-small cell lung cancer (NSCLC)

  • S Nagase, M Tsuboi, expression Suzuki K et al Individualized adjuvant chemotherap mRNA
  • J Clin Oncol (suppl; abstr e17506) 6942 Mol Biol…
  • 2012
1 Excerpt

Similar Papers

Loading similar papers…